Enliven Therapeutics Inc
(ELVN)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ELVN | ARDX | ORKA | ||
| Company | Enliven Therapeutics Inc | Ardelyx Inc | Oruka Therapeutics Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 27.25 | 7.00 | 32.81 | ||
| High | 28.05 | 7.18 | 33.96 | ||
| Low | 26.68 | 6.85 | 31.95 | ||
| Latest | 26.72 | 6.87 | 32.21 | ||
| Change | -0.44 | -0.14 | -0.43 | ||
| % Change | -1.62% | -2.00% | -1.32% | ||
| Volume | 436,300 | 2,787,400 | 187,000 | ||
| 20-Day Average Volume | 870,920 | 4,077,665 | 460,285 | ||
| Previous Close | 27.16 | 7.01 | 32.64 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 27.06 | 7.51 | 33.71 | ||
| 20-Day Raw Stochastic | 35.19% | 8.38% | 21.96% | ||
| 20-Day Relative Strength | 56.90 | 48.45 | 50.86 | ||
| Weighted Alpha | -5.65 | +26.04 | +228.97 | ||
| Today's Opinion | 88% Buy | 88% Buy | 88% Buy | ||
| Previous Opinion | 100% Buy | 88% Buy | 88% Buy | ||
| Last Month's Opinion | 8% Buy | 100% Buy | 96% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -9.18% since 02/06/26 | -6.15% since 02/06/26 | -2.54% since 02/06/26 | ||
| Low | 26.43 on 02/11/26 | 6.85 on 02/13/26 | 31.00 on 02/11/26 | ||
| High | 29.42 on 02/09/26 | 7.43 on 02/10/26 | 33.96 on 02/13/26 | ||
| 1-Month | |||||
| %Chg | +3.77% since 01/13/26 | -2.41% since 01/13/26 | +2.78% since 01/13/26 | ||
| Low | 24.29 on 01/15/26 | 6.73 on 01/16/26 | 30.96 on 01/14/26 | ||
| High | 30.22 on 02/06/26 | 8.40 on 01/23/26 | 36.51 on 01/22/26 | ||
| 3-Month | |||||
| %Chg | +31.82% since 11/13/25 | +17.84% since 11/13/25 | +22.10% since 11/13/25 | ||
| Low | 14.78 on 01/06/26 | 5.30 on 11/21/25 | 25.23 on 01/05/26 | ||
| High | 30.22 on 02/06/26 | 8.40 on 01/23/26 | 36.51 on 01/22/26 | ||
| 6-Month | |||||
| %Chg | +33.70% since 08/13/25 | +19.48% since 08/13/25 | +110.11% since 08/13/25 | ||
| Low | 14.78 on 01/06/26 | 4.71 on 10/13/25 | 14.08 on 08/19/25 | ||
| High | 30.22 on 02/06/26 | 8.40 on 01/23/26 | 36.51 on 01/22/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 1,585,752 | 1,669,218 | 1,559,254 | ||
| Shares Outstanding, K | 59,347 | 242,972 | 48,409 | ||
| Annual Sales | 0 | 333,620,000 | 0 | ||
| Annual Net Income | -89,020,000 | -39,140,000 | -83,720,000 | ||
| Last Quarter Sales | 0 | 110,330,000 | 0 | ||
| Last Quarter Net Income | -20,150,000 | -970,000 | -30,280,000 | ||
| 60-Month Beta | 0.34 | 0.57 | -0.38 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.32 on 11/12/25 | 0.00 on 10/30/25 | -0.55 on 11/12/25 | ||
| Latest Earnings Date | 03/12/26 | 02/19/26 | 03/05/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||